Clive Sharpe - Chairman Novomins

Gummy supplement brand Novomins has appointed industry veteran Clive Sharpe as its non-executive chairman.

Starting this month, he will spearhead Novomins expansion into the US, the company having already achieved revenunes of £2.5m since launching in 2020.

Sharpe said he was “delighted” to join the firm “at an exciting stage of the company’s development as it continues to pursue a high growth agenda”.

“The Novomins range of gummy vitamins and supplements is unique in its combination of great taste and science-based formulations, addressing a variety of consumer health needs.”

Sharpe’s appointment follows decades of experience in consumer goods, including his latest role as co-founder and chair of CBD brand Cannaray, from which he departed only last week amid a merger with Cellular Goods.

He has also previously worked as a CEO for Golden Wonder and Homepride Foods and helped facilitate the sale of Quorn to Monde Nissin.

Within private equity he was worked with Bridgepoint Capital, Blackstone, Exponent pe, L&G Ventures, ABN Amro, NBGI, Intermediate Capital Group, and Actis.

Novomins chief medical officer and co-founder Peter McQuillan said: “Our plan to create a delicious blend of potent supplements has now become a public demand as we expand deeper in women’s health and child nutrition.

“Now with Clive joining the team we are ready to expand into the US market.”